MISTER SPEX: FY21 results in line with expectations and FY22 outlook confirms a gradual improvement | BUY | EUR30
MISTER SPEX - BUY | EUR30FY21 results in line with expectations and FY22 outlook confirms a gradual improvement
FY21 sales in line with CS expectations and FY guidance
FY21 aEBITDA matched FY guidance despite an unfavourable product-mix in H2
Vague FY22 outlook but that implies a sequential improvement at sales and earnings levels
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.